Letrozole 98.0%(HPLC)
98.0%(HPLC)
Properties
| Water Solubility | Insoluble |
| Assay Purity | >98%(HPLC) |
| Refractive index | 1.615 |
| B pt. | 374.4℃ at 760 mmHg |
| M pt. | 185℃ |
| Density | 1.21g/cm3 |
Safety Information
| Hazard Statement(s) | H302 + H312 + H332-H315-H319-H360-H362 |
| Precautionary Statement | P501-P263-P260-P270-P202-P201-P271-P264-P280-P308 + P313 -P337 + P313-P305 + P351 + P338-P362 + P364-P332 + P313-P301 + P312 + P330-P302 + P352 + P312-P304 + P340 + P312-P405 |
| Symbol |
|
| Signal word | Danger |
| HS Code | 2933990090 |
| Flash point | 180.3℃ |
| Storage Temp. | 0-10℃ |
| Packaging | Glass bottle |
Description
Application
Letrozole has been used to investigate steroid receptor coactivator-1 (SRC-1) mediated endogenous estrogen regulation of hippocampal PSD-95(49).
Purpose
For R&D use onlynot for drug household or other uses.
General Description
Letrozole (INN trade name Femara) is an oral non-steroidal aromatase inhibitor for the treatment of hormonally-responsive breast cancer after surgery.
Documents
| SDS |
| COA |
| Specification |
| Bulk quote order form |